Efficacy and Safety of Oral Febuxostat in Participants With Gout
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of febuxostat, once Daily
(QD), to allopurinol in subjects with hyperuricemia and gout.